Table 1. Screening of quinoides 1–5 and VEGFR2-TKIs 6–10 in HCC cell lines.
Compound | IC50 (μM)
a
|
||
Huh7 | Hep3B | Mahlavu | |
1 | 7.0 ± 0.8 | 12.0 ± 1.7 | 18.3 ± 0.8 |
2a | 8.0 ± 0.9 | 5.5 ± 1.8 | 14.5 ± 1.3 |
2b | 5.5 ± 0.4 | 4.3 ± 0.7 | 11.6 ± 0.2 |
3 | 20.0 ± 1.7 | 17.4 ± 2.1 | 31.3 ± 0.3 |
4 | 10.6 ± 2.0 | 9.9 ± 2.3 | 11.3 ± 0.6 |
5 | Ni | Ni | Ni |
6 | 1.6 ± 0.8 | 1.5 ± 0.3 | 0.7 ± 0.4 |
7 | 2.8 ± 1.3 | 2.0 ± 0.9 | 3.0 ± 0.5 |
8 | 1.7 ± 0.7 | 2.1 ± 0.3 | 0.8 ± 0.5 |
9 | 1.5 ± 0.7 | 0.7 ± 0.1 | 1.2 ± 0.4 |
10 | 0.4 ± 0.3 | 0.9 ± 0.3 | 1.1 ± 0.7 |
DAPT | 5.0 ± 1.2 | 5.0 ± 2.0 | 5.0 ± 1.5 |
aExperiments were performed in triplicate; Ni: no growth inhibition.